RxSight Inc (RXST)
51.48
+0.38
(+0.74%)
USD |
NASDAQ |
Nov 04, 13:10
RxSight Price to Book Value: 7.423 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 7.368 |
| October 31, 2024 | 7.305 |
| October 30, 2024 | 7.384 |
| October 29, 2024 | 7.521 |
| October 28, 2024 | 7.246 |
| October 25, 2024 | 7.264 |
| October 24, 2024 | 7.148 |
| October 23, 2024 | 6.995 |
| October 22, 2024 | 7.251 |
| October 21, 2024 | 7.285 |
| October 18, 2024 | 7.277 |
| October 17, 2024 | 7.214 |
| October 16, 2024 | 7.305 |
| October 15, 2024 | 7.153 |
| October 14, 2024 | 7.247 |
| October 11, 2024 | 7.238 |
| October 10, 2024 | 7.195 |
| October 09, 2024 | 7.114 |
| October 08, 2024 | 7.102 |
| October 07, 2024 | 6.956 |
| October 04, 2024 | 7.051 |
| October 03, 2024 | 6.900 |
| October 02, 2024 | 6.858 |
| October 01, 2024 | 6.799 |
| September 30, 2024 | 7.127 |
| Date | Value |
|---|---|
| September 27, 2024 | 6.999 |
| September 26, 2024 | 7.051 |
| September 25, 2024 | 7.054 |
| September 24, 2024 | 7.050 |
| September 23, 2024 | 7.435 |
| September 20, 2024 | 7.639 |
| September 19, 2024 | 7.724 |
| September 18, 2024 | 7.810 |
| September 17, 2024 | 8.095 |
| September 16, 2024 | 8.008 |
| September 13, 2024 | 7.925 |
| September 12, 2024 | 7.864 |
| September 11, 2024 | 7.864 |
| September 10, 2024 | 7.708 |
| September 09, 2024 | 7.722 |
| September 06, 2024 | 7.635 |
| September 05, 2024 | 7.714 |
| September 04, 2024 | 7.769 |
| September 03, 2024 | 7.670 |
| August 30, 2024 | 8.131 |
| August 29, 2024 | 7.998 |
| August 28, 2024 | 7.850 |
| August 27, 2024 | 8.156 |
| August 26, 2024 | 8.055 |
| August 23, 2024 | 8.140 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.726
Minimum
Dec 20 2021
15.39
Maximum
May 15 2024
5.846
Average
5.200
Median
Feb 15 2023
Price to Book Value Benchmarks
| Tandem Diabetes Care Inc | 9.229 |
| Twist Bioscience Corp | 4.993 |
| Perspective Therapeutics Inc | 2.447 |
| Xtant Medical Holdings Inc | 1.636 |
| Catheter Precision Inc | 0.1009 |
Price to Book Value Related Metrics
| PS Ratio | 16.42 |
| Price | 51.48 |
| Earnings Yield | -1.96% |
| Market Cap | 2.043B |